Austria: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Austria

The Austrian market for other medicaments for therapeutic or prophylactic uses dropped modestly to $X in 2022, waning by X% against the previous year. In general, consumption showed strong growth. Over the period under review, the market reached the peak level at $X in 2019; however, from 2020 to 2022, consumption remained at a lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Austria

In value terms, production of other medicaments for therapeutic or prophylactic uses contracted to $X in 2022 estimated in export price. Over the period under review, production, however, continues to indicate a significant expansion. The most prominent rate of growth was recorded in 2018 with an increase of X%. Production of peaked at $X in 2019; however, from 2020 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Austria

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the second consecutive year after two years of growth. In general, exports, however, posted mild growth. The pace of growth was the most pronounced in 2014 when exports increased by X%. Over the period under review, the exports of hit record highs at X tons in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses shrank to $X in 2022. Overall, exports, however, posted a mild increase. The growth pace was the most rapid in 2016 when exports increased by X%. The exports peaked at $X in 2021, and then declined in the following year.

Exports by Country

Japan (X tons), Iran (X tons) and the United States (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Austria, with a combined X% share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Japan (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the United States ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Austria, comprising X% of total exports. The second position in the ranking was held by Italy ($X), with a X% share of total exports. It was followed by Japan, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the United States amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Italy (X% per year) and Japan (X% per year).

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, reducing by X% against the previous year. In general, the export price saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2021 an increase of X% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2013; however, from 2014 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Slovenia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Switzerland (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Austria

Imports of other medicaments for therapeutic or prophylactic uses into Austria expanded remarkably to X tons in 2022, increasing by X% compared with 2021. Over the period under review, total imports indicated a pronounced increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2013 when imports increased by X%. Imports peaked at X tons in 2014; however, from 2015 to 2022, imports remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses reduced modestly to $X in 2022. In general, total imports indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by X% against 2019 indices. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. Over the period under review, imports of reached the peak figure at $X in 2019; however, from 2020 to 2022, imports remained at a lower figure.

Imports by Country

Singapore (X tons), Germany (X tons) and Italy (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Austria, together comprising X% of total imports. Denmark, the Netherlands, Switzerland, Slovakia, the United States and the UK lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Denmark (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest other medicaments for therapeutic or prophylactic uses suppliers to Austria were Italy ($X), Switzerland ($X) and Singapore ($X), together accounting for X% of total imports. Germany, Denmark, the Netherlands, Slovakia, the United States and the UK lagged somewhat behind, together comprising a further X%.

Denmark, with a CAGR of X%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, falling by X% against the previous year. Overall, import price indicated a slight increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for other medicaments for therapeutic or prophylactic uses increased by X% against 2020 indices. The growth pace was the most rapid in 2015 when the average import price increased by X% against the previous year. The import price peaked at $X per ton in 2019; however, from 2020 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Switzerland ($X per ton), while the price for the Netherlands ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :